Company: CXAI
Filing Date: 2025-05-09
Form Type: S-1
Source: 0001829126-25-003532
Chunk: 20

Company: CXApp Inc.
Filing Date: 2025-05-09
Form: S-1
Chunk 20
---
 Purchases subject to the Avondale Purchase Agreement |
| Selling Securityholders                                       |     | Avondale Capital, LLC. See “Selling Securityholders” on page 86 of this prospectus.                                                  |                                                                                                                                      |
| Shares of common stock outstanding prior to this offering     |     | 20,776,997 shares of common stock (as of May 8, 2025)                                                                                |                                                                                                                                      |
| Use of proceeds                                               |     | We will not receive any proceeds from the sale of shares of common stock by the Selling Securityholders pursuant to this prospectus. |                                                                                                                                      |
| Risk factors                                                  |     | You should carefully read the section titled                                                                                         
 “Risk Factors” beginning on page 14 and the other information included in this prospectus for a discussion of                        
 factors you should consider carefully before deciding to invest in our common stock.                                                 |                                                                                                                                      |
| Nasdaq symbol for our common stock                            |     | “CXAI”                                                                                                                               |                                                                                                                                      |

<div align='center'>13</div>

<div align='center'>Risk Factors</div>

You should carefully consider the risks and uncertainties described below and the other information in this prospectus before making an investment in our common stock or warrants. Our business, financial condition, results of operations, or prospects could be materially and adversely affected if any of these risks occurs, and as a result, the market price of our common stock and warrants could decline and you could lose all or part of your investment. This prospectus also contains forward-looking statements that involve risks and uncertainties. See “Cautionary Statement Regarding Forward-Looking Statements.” Our actual results could differ materially and adversely from those anticipated in these forward-looking statements as a result of certain factors, including those set forth below.

Risks Related to this Offering by the Selling Securityholders

Sales of a substantial number of our securities in the public market by the Selling Securityholders and/or by our existing securityholders could cause the price of our shares of common stock and warrants to fall.

The Selling Securityholders
can sell, under this prospectus, up to 18,500,000 shares of common stock constituting approximately 89% of our issued and outstanding
shares of common stock as of May 8, 2025, consisting of (i) up to 80,000 shares of common stock issued in private placement to Avondale
and (ii) the maximum number of up to 18,420,000 shares issuable to Avondale under the pre